CRELD2 Antibody Blocking peptide
CRELD2 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Cysteine-rich with EGF-like domain protein 2, CRELD2
UniProt
Q6UXH1
Field of Research
Cell Biology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928058 was selected from the C-term region of human CRELD2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2941460-01 250 mg
Ethyl 4,6- (4-methoxybenzylidene) -β-D-thiogalactopyranoside
Sign In for Pricing
View Details orb2941460-02 50 mg
Ethyl 4,6- (4-methoxybenzylidene) -β-D-thiogalactopyranoside
Sign In for Pricing
View Details orb2941460-03 100 mg
Ethyl 4,6- (4-methoxybenzylidene) -β-D-thiogalactopyranoside
Sign In for Pricing
View Details 
GTR15098086 1 Vial
Lentiviral human LCAT shRNA (UAS) - Lentiviral human LCAT shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
IRBAHUCREB1AP099120UL 120 µL
Rabbit Anti Human CREB1 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4) (IHC) 120ul
Sign In for Pricing
View Details 